Travere Therapeutics, Inc.
TVTX· Nasdaq
TVTXTravere Therapeutics, Inc.
Filed May 24, 2012 · 10-K · 85 days after period end · 0001225279-12-000073
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$4.26K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Travere Therapeutics, Inc. · CIK 1438533 · Engraved from SEC EDGAR
ended Feb 29, 2012 · filed May 24, 2012 · 85 d after period end
